Nitto Pharmaceutical Industries

Nitto Pharmaceutical Industries is a Japanese pharmaceutical company specializing in the research, development, and manufacturing of microbiome-based products and lactic acid bacteria. Founded in 1947 and headquartered in Kyoto, the company operates as a Contract Development and Manufacturing Organization (CDMO) while maintaining a proprietary pipeline focused on gastrointestinal health. Their flagship product, Lacris-S (Bacillus coagulans), is a heat-resistant probiotic widely used in pharmaceuticals and functional foods globally. The company's R&D efforts are centered on leveraging beneficial bacteria for treating conditions such as ulcerative colitis and other metabolic disorders. Nitto Pharmaceutical Industries provides end-to-end services from strain isolation and cultivation to final drug formulation and packaging.